MarketResearchNest.com adds “Global Intravenous Access Devices Market 2017-2021” new report to
its research database. The report spread across 105 pages with table and
figures in it.
Research
analysts forecast the global intravenous access devices market to grow
at a CAGR of 5.22% during the period 2017-2021.
About Intravenous Access Devices
Intravenous access devices can be inserted into
peripheral or central veins for the administration of fluids and nutritional
compounds (hyperalimentation); delivery of medications such as antibiotics,
chemotherapy drugs, and other intravenous drugs; blood transfusions; and blood
collection for diagnostic purpose. Vascular access is one of the essential
components of patient care in both hospitals and ambulatory care centers.
Intravenous access devices are most commonly used for administration of fluids
and nutritional compounds, delivery of medications, blood transfusions, and
blood collection for diagnostic purpose. Intravenous access devices are thin
tubes made of medical grade materials such as plastic, silicone rubber,
polyvinyl chloride (PVC), and nylon. Various intravenous access devices are
available, which can be inserted peripherally or centrally, for the safe and
reliable venous access in daily clinical practice.
Covered in this report
The report covers the present scenario and the growth
prospects of the global intravenous access devices market for 2017-2021. To
calculate the market size, the report considers the revenue generated from the
sales of intravenous access devices.
Browse full table of contents and
data tables at https://www.marketresearchnest.com/global-intravenous-access-devices-market-2017-2021.html
The market is divided into the following segments based
on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Intravenous Access Devices
Market 2017-2021, has been prepared based on an in-depth market analysis with
inputs from industry experts. The report covers the market landscape and its
growth prospects over the coming years. The report also includes a discussion
of the key vendors operating in this market.
Technavio recognizes the following companies as the key
players in the global intravenous access devices market: B. Braun Melsungen,
BD, C. R. Bard, Smiths Medical, and TERUMO CORPORATION
Other Prominent Vendors in the market are: AngioDynamics, APEXMED International, Baxter,
Cook Medical, Delta Med, EXELINT International, Fresenius, GaltNeedleTech,
Global Medikit, Hospira, ICU Medical, Medtronic, NIPRO Medical, Promed Group,
RenovoRx, Retractable Technologies, Teleflex, Vigmed, and Vygon.
Commenting on the report, an analyst from Research team
said: “The latest trend gaining momentum in the market is Rise in popularity of
antimicrobial-coated CIVCs. Intravenous access devices are essential for
providing fluids, medications, and intravenous nutrition. They are also used to
provide cancer treatment to patients. Intravenous access devices such as CIVCs
are longer and reach deeper into the major veins of the body. They provide
secure and durable intravenous access. However, CRBSIs and thrombosis are
common in patients with CVCs. They have a significant impact on the market.
This includes increasing healthcare expenses and morbidity and mortality in
hospitalized patients.
Order a Purchase Report Copy at
https://www.marketresearchnest.com/purchase.php?reportid=285074
According to the report, one of the major drivers for
this market is Increase in number of hospitalizations. The number of
hospitalizations is increasing across the world. This is due to the growth of
the global population and the increasing prevalence of various acute and
chronic diseases. In the US, the total number of inpatient hospitalizations
increased by 15% from 31.7 million in 2000 to 36.5 million in 2012. According
to the CDC, in 2014, there were 141.4 million emergency department visits that
resulted in 11.2 million hospital admissions and 1.8 million critical care unit
admissions in the US. In 2014, about 20 million people visited physicians'
offices for cancer as the primary diagnosis, 17.8 million people visited
physicians' offices and 3.9 million people visited hospital outpatient
departments due to infectious and parasitic diseases in the US. According to
the CDC, in 2015, 4.9 million adults were diagnosed with kidney diseases in the
US.
Further, the report states that one of the major factors
hindering the growth of this market is Complications associated with
intravenous access devices. Intravenous access devices such as intravenous
catheters are found to be the most common sources of bacteremia and fungemia.
Intravenous catheters predispose the patient to the risks of local and systemic
infections such as CRBSIs, septic thrombophlebitis, endocarditis, and other
metastatic infections such as lung abscess, brain abscess, osteomyelitis, and
endophthalmitis. Infiltration, phlebitis, and dislodgement are the three most
common mechanical complications associated with intravenous catheters.
The study was conducted using an objective combination of
primary and secondary information including inputs from key participants in the
industry. The report contains a comprehensive market and vendor landscape in
addition to a SWOT analysis of the key vendors.
Enquiry before
Buying at https://www.marketresearchnest.com/enquirybuy.php?reportid=285074
About:
MarketResearchNest.com is
the most comprehensive collection of market research products and services on
the Web. We offer reports from almost all top publishers and update our
collection on daily basis to provide you with instant online access to the
world’s most complete and recent database of expert insights on industries,
organizations, products, and trends.
Contact
Mr. Jeet Jain
Sales Manager
+1-240-284-8070(U.S)
+44-20-3290-4151(U.K)
Connect with us: Google+ | LinkedIn | Twitter | Facebook
